Champlain Investment Partners LLC 13D and 13G filings for Cardiovascular Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 3:24 pm Sale |
2023-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
Champlain Investment Partners LLC | 0 0.000% |
-2,338,085 (Position Closed) |
Filing |
| 2023-02-13 1:26 pm Sale |
2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
Champlain Investment Partners LLC | 2,338,085 5.580% |
-1,150,540 (-32.98%) |
Filing |
| 2022-02-11 10:55 am Purchase |
2021-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
Champlain Investment Partners LLC | 3,488,625 8.600% |
417,455 (+13.59%) |
Filing |
| 2021-02-12 1:24 pm Purchase |
2020-12-31 | 13G | Cardiovascular Systems, Inc. CSII |
Champlain Investment Partners LLC | 3,071,170 7.650% |
672,975 (+28.06%) |
Filing |